Zobrazeno 1 - 10
of 181
pro vyhledávání: '"C Campas"'
Autor:
C. Montagut, Joan Albanell, B Ferrer, E Campo, M. Suárez, Ana Rovira, P.L. Fernández, J M Corominas, Pedro Gascón, X Fabregat, B Bellosillo, S. Serrano, C Campas, Ignasi Tusquets
Publikováno v:
Endocrine-Related Cancer. 13:607-616
The nuclear factor (NF)-kappaB system is a promising anticancer target due to its role in oncogenesis and chemoresistance in preclinical models. To provide evidence in a clinical setting on the role of NF-kappaB in breast cancer, we aimed to study th
Autor:
C. Campas-Moya
Publikováno v:
Drugs of the Future. 36:567
Autor:
C. Campas-Moya
Publikováno v:
Drugs of the Future. 35:457
Publikováno v:
Drugs of the Future. 34:793
Autor:
N. Villena, Cristiana Sessa, I. Corradino, C. Campas, Federico Rojo, Teresa Cruz, M. Cedeño, E. Gracias, Tania Crombet, Joan Albanell
Publikováno v:
Journal of Clinical Oncology. 26:6070-6070
6070 Background: Nimotuzumab (N) is a humanized MAb to EGFR that has shown evidence of efficacy in patients (pts) with advanced solid tumors, notably without provoking skin rash. Although lack of r...
Publikováno v:
Drugs of the Future. 33:0649
Autor:
C. Campas, R. Castañer
Publikováno v:
Drugs of the Future. 33:1012
Autor:
C. Campas, R. Castañer
Publikováno v:
Drugs of the Future. 33:838
Autor:
González-Pereira, Priscilla1 (AUTHOR) pgonzalezpereira@gmail.com, Trinh, Ryan2 (AUTHOR), Vasuthasawat, Alex2 (AUTHOR), Bartsch-Jiménez, Angelo3 (AUTHOR) angelo.bartsch@uv.cl, Nuñez-Soto, Constanza1 (AUTHOR), Altamirano, Claudia1,4,5 (AUTHOR) claudia.altamirano@pucv.cl
Publikováno v:
Bioengineering (Basel). Mar2024, Vol. 11 Issue 3, p201. 18p.
Autor:
Schauenburg, Dominik1 (AUTHOR) schauenburgd@mpip-mainz.mpg, Weil, Tanja1,2 (AUTHOR) weil@mpip-mainz.mpg.de
Publikováno v:
Advanced Science. 2/23/2024, Vol. 11 Issue 8, p1-22. 22p.